UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer
UT Southwestern Medical Center ranked fourth in the nation and No. 1 in Texas for commercializing new biomedical technologies, considered a critical step in bringing its laboratory discoveries into clinical practice.
Over the years, UT Southwestern scientists have been issued nearly 750 patents and disclosed more than 4,000 innovations, with the University issuing more than 1,100 licenses and options to business partners, resulting in more than $278 million in licensing revenues for the University. Ninety startups have been launched off UTSW technologies, including Taysha Gene Therapies, ReCode Therapeutics, OncoNano Medicine, Exonics Therapeutics, Rodeo Therapeutics, and Peloton Therapeutics.